US Patent Issued to Ioulia TSETI, Uni-Pharma Kleon Tsetis Pharmaceuticals Laboratories on July 14 for "L-triiodothyronine (T3) for use in limiting microvascular obstruction" (Greek Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,416, issued on July 14, was assigned to Ioulia TSETI (Attica, Greece) and Uni-Pharma Kleon Tsetis Pharmaceuticals Laboratories S.A. (Attica, Greece).

"L-triiodothyronine (T3) for use in limiting microvascular obstruction" was invented by Constantinos Pantos (Kantza, Greece) and Iordanis Mourouzis (Korydallos, Greece).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns the use of L-triiodothyronine (T3) in a novel treatment to limit or prevent the occurrence of Microvascular Obstruction (MVO), after a successful Primary Percutaneous Coronary Intervention (PPCI), in the course of an acute ST-segment-elevation myocardial infarc...